Zain Khalpey/LinkedIn
Dec 19, 2025, 09:24
Zain Khalpey on A New Study Linking Low-dose Aspirin to Reduced Cancer Spread
Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared on LinkedIn:
”A paper in The New England Journal of Medicine outlines a mechanism by which low-dose aspirin may reduce cancer spread, particularly in colorectal cancer and in individuals with certain mutations or CHIP.
By lowering platelet activation and thromboxane A2 signaling, aspirin helps release T cells from immune suppression and supports antimetastatic immunity.
Follow Zain Khalpey for more on Ai and Healthcare.”
Read the full article in NEJM.
Article: Understanding How Aspirin Prevents Metastasis
Authors: Ruth E. Langley, John Burn
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 19, 2026, 18:29Rameez Ashraff: Have You Noticed Neutrophil Inclusions in a Thrombocytopenia Smear?
-
Mar 19, 2026, 18:07Leonardo Roever: A Consensus Framework for Biomarker Research and Clinical Translation in Stroke
-
Mar 19, 2026, 17:49Matteo Foschi: Breaktrough Stroke on Oral Anticoaugulants for Atrial Fibrillation
-
Mar 19, 2026, 17:30UK Haemophilia Society Continues to Empower Individuals and Families Through Advocacy, Education, and Community Support – WFH
-
Mar 19, 2026, 17:20Dimitrios Nikas: Stroke During TAVI Procedures Still Remains Noticeable High
-
Mar 19, 2026, 17:14Akinchan Bhardwaj: Differences in Bleeding Outcomes Among DOACs
-
Mar 19, 2026, 17:03How Personal Experiences Can Support Self‑Advocacy and Help Improve Healthcare Outcomes – Hemophilia Alliance
-
Mar 19, 2026, 16:54X. Long Zheng: Unpacking the Real-World Challenges of ADAMTS13 on ISTH Pulse Podcast
-
Mar 19, 2026, 16:50Zain Khalpey: Predictive Imaging and AI in Aortic Dissection Risk Assessment